Month: May 2021

SAN JOSE, Calif., May 12, 2021 (GLOBE NEWSWIRE) — Highlights: Released proprietary patent-pending software for visibility into encrypted network traffic Nine-month revenue $1,734,024, 1372% growth in revenue over the prior comparable period Over 3X growth in sales funnel entering fiscal 2022 A scalable business model with a path to profitability Large addressable market with growing disruption and need San Jose, Calif., May 12, 2021 —  Nubeva Technologies Ltd. (“Nubeva ” or the “Company”) (TSX-V: NBVA, OTC: NBVAF), a developer of decryption software that broadens network traffic security and visibility, provides corporate updates from the Chief Executive Officer, Randy Chou. “Over the past 18 months, Nubeva has achieved foundational milestones that, together with industry...

TMS-007 has the potential to be a next generation thrombolytic with an improved benefit-risk profile Acute ischemic stroke is caused by a blockage of blood supply to the brain, and current thrombolytics are limited in use due in part to increased risks of bleeding Phase 2a study demonstrated positive impacts on blood vessel reopening and patient functional recovery with no incidence of symptomatic intracranial hemorrhage Biogen to make a one-time payment of $18 million and may pay potential milestone payments and royalties to TMS Co., Ltd.CAMBRIDGE, Mass. and FUCHU-SHI, Tokyo, May 12, 2021 (GLOBE NEWSWIRE) — Biogen Inc (Nasdaq: BIIB) and TMS Co., Ltd. announced today that Biogen exercised its option to acquire TMS-007, an investigational drug for acute ischemic stroke, from TMS. Biogen’s decision to acquire TMS-007 was based...

Kindred to bring the up-and-coming company’s cannabis products to locations across Canada TORONTO, May 12, 2021 (GLOBE NEWSWIRE) — Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) a Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products as a strategic partner to other LP’s in Canada, is pleased to announce a new exclusive partnership with Kindred Partners Inc., a Toronto-based specialty cannabis brokerage serving the adult recreational use market. This new agreement will allow Ayurcann greater access to the recreational cannabis market. “With this new arrangement, we are poised to grow faster than ever,” said Igal Sudman, CEO of Ayurcann. “Kindred’s commitment to education and strong relationships with the provincial boards nationwide,...

Today, the Board of Directors of H+H International A/S (hereinafter referred to as “H+H” or “the Group”) has adopted the Interim Financial Report for the first quarter of 2021 (“Q1 2021”). CEO Michael T. Andersen quote “I am very pleased with the positive demand outlook across all our markets, which has driven the upgrade of our full-year financial expectations. Despite a slow-down in demand in Germany and Poland in the early months of 2021 caused by the strongest weather impact in a decade, activity has quickly picked up and is now gaining momentum. The UK market is looking particularly strong with solid forward sales reported by housebuilders in recent trading updates indicating building activity in the UK potentially returning to the historic high 2019-levels already this year.” Performance highlights for Q1 2021Industry hit by strongest...

PIPESTONE DEVELOPMENT MAPPIPESTONE DEVELOPMENT MAPCALGARY, Alberta, May 12, 2021 (GLOBE NEWSWIRE) — (PIPE – TSX) Pipestone Energy Corp. (“Pipestone” or the “Company”) is pleased to report its Q1 2021 financial and operational results, as well as provide an update on its operations. Pipestone continues to efficiently grow its highly economic condensate-rich Montney asset. The Company is well on track to deliver its 2021 production guidance of 24,000 to 26,000 boe/d. The increase in natural gas and condensate prices, coupled with improving capital efficiencies and strong well results, positions Pipestone to deliver significant annual free cash flow for shareholders beginning in Q4 2021 and beyond. Pipestone also generated strong returns on invested capital during the quarter, with annualized ROCE and CROIC of 10.9%...

REDWOOD CITY, Calif., May 12, 2021 (GLOBE NEWSWIRE) — Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve, today provided an update on recent corporate developments and reported financial results for the quarter ended March 31, 2021. Recent Corporate DevelopmentsFull-data analysis from 12-month treatment phase of ALTISSIMO Phase 2b trial in wet AMD— GB-102 1mg has shown competitive durability and anatomical control versus aflibercept; trend in mean BCVA of GB-102 1mg compared to aflibercept driven primarily by a subgroup of patients. Six-month observational trial extension of ALTISSIMO still underway— 14 of 28 patients enrolled have completed at least five months of the extension period without...

Iceland Seafood will publish its interim consolidated financial statement for Q1 2021 after closing of markets on May 17th 2021. The same day at 4.15pm, the company will host an online meeting for investors and market participants, where management will present and discuss the results. The meeting will be webcasted live in Icelandic. A link to the webcast and investor presentation will be provided before the meeting commence.  Participants to the meeting can send questions in writing prior and during the meeting to the email investors@icelandseafood.com.

– ImmunoPhage™ platform programs and the VISTA program continue to advance – – New safety and efficacy data from ongoing Phase 1/2 combination study of SNS-301 in squamous cell carcinoma of the head and neck accepted for presentation at ASCO 2021 –     – Patient dosing underway in second cohort of Phase 1/2 combination study of SNS-301 in patients with no prior treatment with PD-1 blockade – – Ended quarter with a strong cash position of $169.4 million, runway at least into second half of 2023 – BOSTON and ROCKVILLE, Md., May 12, 2021 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical-stage immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today reported financial results for the first quarter ended March...

SHANGHAI, China, May 12, 2021 (GLOBE NEWSWIRE) — Smart Share Global Limited (“Energy Monster” or the “Company”), a consumer tech company providing mobile device charging service, today announced that it plans to release its unaudited first quarter 2021 financial results on Wednesday, May 19, 2021, before the U.S. market opens. Smart Share Global Limited’s management will hold a conference call at 08:00 A.M. Eastern Time on Wednesday, May 19, 2021 (08:00 P.M. Beijing Time on Wednesday, May 19, 2021) to discuss the financial results. Listeners may access the call by dialing the following numbers:International: +65-6713-5330United States: +1-347-549-4094Mainland China: 400-820-6895China Hong Kong: +852-3018-8307   Conference ID / Passcode: 2663446A telephone replay will be available through May 27, 2021....